These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7931053)

  • 1. The effect of Fiberform, a low-phytate wheat fibre, on plasma lipids and blood pressure of women with familial hypercholesterolaemia.
    Lansberg PJ; Knipscheer HC; Kastelein JJ; Prins MH; van der Ende AE
    J Intern Med; 1994 Oct; 236(4):477-8. PubMed ID: 7931053
    [No Abstract]   [Full Text] [Related]  

  • 2. Colestipol tablets in adolescents with familial hypercholesterolaemia.
    Tonstad S; Ose L
    Acta Paediatr; 1996 Sep; 85(9):1080-2. PubMed ID: 8888922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol, lipids and arterial stiffness.
    Wilkinson I; Cockcroft JR
    Adv Cardiol; 2007; 44():261-277. PubMed ID: 17075215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gemfibrozil plus cholestyramine in familial hypercholesterolaemia.
    Jones AF; Hughes EA; Cramb R
    Lancet; 1988 Apr; 1(8588):776. PubMed ID: 2895309
    [No Abstract]   [Full Text] [Related]  

  • 5. Low dose colestipol in adolescents with familial hypercholesterolaemia.
    Tonstad S; Sivertsen M; Aksnes L; Ose L
    Arch Dis Child; 1996 Feb; 74(2):157-60. PubMed ID: 8660081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of the combined administration of guar-bezafibrate on lipid, apolipoprotein and lipoprotein in patients with primary hyperlipoproteinemia type II].
    Wirth A; Schlierf G; Middelhoff G; Arntz HR; Hansen W; Vollmar J; Bräuning C
    Beitr Infusionther Klin Ernahr; 1983; 12():99-108. PubMed ID: 6316922
    [No Abstract]   [Full Text] [Related]  

  • 7. CI-924 effects on plasma lipids in patients with type II and type IV hyperlipoproteinaemia.
    Corder CN; Kloer HU; Price MD
    Eur J Clin Pharmacol; 1989; 37(5):477-81. PubMed ID: 2598985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of wheat fibre supplements on duodenal ulcer recurrence.
    Rydning A; Børkje B; Lange O; Aadland E; Bell H; Odegaard Myklestad B; Hansen T
    Scand J Gastroenterol; 1993 Dec; 28(12):1051-4. PubMed ID: 8303206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of fenofibrate and simvastatin on plasma sICAM-1 and MCP-1 concentrations in patients with hyperlipoproteinemia.
    Kowalski J; Okopien B; Madej A; Zielinski M; Belowski D; Kalina Z; Herman ZS
    Int J Clin Pharmacol Ther; 2003 Jun; 41(6):241-7. PubMed ID: 12816176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of a fibre supplement compared to a healthy diet on body composition, lipids, glucose, insulin and other metabolic syndrome risk factors in overweight and obese individuals.
    Pal S; Khossousi A; Binns C; Dhaliwal S; Ellis V
    Br J Nutr; 2011 Jan; 105(1):90-100. PubMed ID: 20727237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of bezamidine on plasma cholesterol and triglyceride levels in patients with familial hyperlipoproteinemia].
    Kukharchuk VV; Koshechkin VA; Konovalov GA; Rozhkova TA; Solov'eva EIu
    Kardiologiia; 1990 Dec; 30(12):16-8. PubMed ID: 2097388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acipimox in combination with low dose cholestyramine for the treatment of type II hyperlipidaemia.
    Series JJ; Gaw A; Kilday C; Bedford DK; Lorimer AR; Packard CJ; Shepherd J
    Br J Clin Pharmacol; 1990 Jul; 30(1):49-54. PubMed ID: 2390432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The use of Enduracin--a prolonged-action form of nicotinic acid--in correcting atherogenic dyslipidemias].
    Oganov RG; Kiseleva NG; Aronov DM; Akhmedzhanov NM; Olfer'ev AM; Kiseleva NS; Perova NV
    Kardiologiia; 1993; 33(10):54-9, 6. PubMed ID: 8139175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid Regression of Multiple-Site Xanthomas in an Adult With Homozygous Familial Hypercholesterolemia by Triple Lipid-Lowering Drugs.
    Wu NQ; Guo YL; Zhu CG; Gao Y; Liu G; Dong Q; Li JJ
    Am J Ther; 2019; 26(6):e775-e777. PubMed ID: 31703038
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug therapy of hyperlipidemia].
    Kajiyama G; Horiuchi I
    Nihon Rinsho; 1990 Nov; 48(11):2620-8. PubMed ID: 2270030
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma lipid lowering activity of acipimox in patients with type II and type IV hyperlipoproteinemia. Results of a multicenter trial.
    Crepaldi G; Avogaro P; Descovich GC; Di Perri T; Postiglione A; Sirtori CR; Strano A; Ventura S; Musatti L
    Atherosclerosis; 1988 Mar; 70(1-2):115-21. PubMed ID: 3281679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anacetrapib as lipid-modifying therapy in patients with heterozygous familial hypercholesterolaemia (REALIZE): a randomised, double-blind, placebo-controlled, phase 3 study.
    Kastelein JJ; Besseling J; Shah S; Bergeron J; Langslet G; Hovingh GK; Al-Saady N; Koeijvoets M; Hunter J; Johnson-Levonas AO; Fable J; Sapre A; Mitchel Y
    Lancet; 2015 May; 385(9983):2153-61. PubMed ID: 25743173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical results with gemfibrozil and background to the Helsinki Heart Study.
    Manninen V
    Am J Cardiol; 1983 Aug; 52(4):35B-38B. PubMed ID: 6351578
    [No Abstract]   [Full Text] [Related]  

  • 19. [Attempt to affect hyperlipoproteinemia in patients by long-term anticoagulant therapy].
    Doĭchinov A; Bŭchvarova V
    Vutr Boles; 1984; 23(5):67-72. PubMed ID: 6098077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of fenofibrate on serum lipoproteins in subjects with familial hypercholesterolemia and combined hyperlipidemia.
    Weisweiler P; Merk W; Janetschek P; Schwandt P
    Atherosclerosis; 1984 Dec; 53(3):321-5. PubMed ID: 6529448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.